Gene Editing Tool Market AnalysisThe global gene editing tool market is on the cusp of a revolutionary expansion, projected to grow at an impressive CAGR of 18.4% from 2024 to 2034. Valued at USD 688.

Applied Real Intelligence ("A.R.I."), a leading provider of early-stage venture debt through the A.R.I. Senior Secured Growth ...

Two Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

The Kobe University start-up Photo-on-Demand Chemical Co. Ltd. demonstrated that it can produce methane from sewage to refine ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

The "Clinical Trials Market in the US 2025-2029" report has been added to ResearchAndMarkets.com's offering. The clinical trials market in the United States is poised for significant expansion with an ...

Hoag Memorial Hospital Presbyterian is spending more than $20 million to open a 20,000-square-foot state-of-the-art health ...

AI in Healthcare Market SizeThe global artificial intelligence (AI) in healthcare market was worth USD 32.51 billion in 2024 ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Healthcare's AI revolution is happening at two speeds: racing ahead with paperwork but proceeding cautiously with patient ...